Ownership Summary
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) has 6 institutional investors with active 13F positions as of March 2026.
- Their combined ownership stood at 4.7% of outstanding shares in March 2026, down from 7.1% in December 2025.
- Their total shares held in OACCU decreased -34.58% quarter over quarter, and separately, investors owning Oaktree Acquisition Corp. III Life Sciences decreased 50.0% from a year ago.
- Of these 6 funds, 1 grew their exposure to Oaktree Acquisition Corp. III Life Sciences, 1 cut back, and 4 maintained positions.
- Altogether, these fund groups held 892.99K shares in OACCU by March 2026, down by 471.96K shares quarter on quarter, and down 2.48Mn shares year over year.
- ADAR1 Capital Management, LLC holds the largest position in OACCU at 516.48K shares as of March 31, 2026, or 2.69% of shares outstanding.
- The largest buyers of Oaktree Acquisition Corp. III Life Sciences for the quarter ending March 2026 were DLD Asset Management, LP (44.52K).
- Leading sellers of Oaktree Acquisition Corp. III Life Sciences shares for the quarter ending March 2026 were ADAR1 Capital Management, LLC (516.48K).
- Oaktree Acquisition Corp. III Life Sciences's 6 largest shareholders as of March 2026 include ADAR1 Capital Management, LLC (516.48K), Affinity Asset Advisors, LLC (250.0K), Athos Capital Ltd (50.0K), DLD Asset Management, LP (44.52K), Clear Street Group Inc. (22.22K), UBS Group AG (9.76K) per Business Quant data.